Bernstein and 16 other SEBI-registered analysts issued 107 short term recommendations across 36 stocks over a two to four week horizon, with a broadly bullish bias.
Bernstein and 16 other SEBI-registered analysts issued 107 equity short term recommendations today, targeting gains over a 2 to 4 week horizon. The batch carries a broadly bullish bias — 85 buys against 22 sells — covering 36 stocks.
The 5 most-covered names of the session:
SUNPHARMA drew 24 calls — 8 buys and 16 sells — from Bernstein, a SEBI-registered analyst, Gaurang Shah, with entries between ₹1,836 and ₹1,849.3 and targets at ₹2,235.
AXISBANK drew 13 calls — 8 buys and 5 sells — from CLSA, with entries between ₹1,232.1 and ₹1,250 and targets at ₹1,550.
MARICO drew 9 calls — 9 buy calls — from Jefferies, with entries between ₹799 and ₹807 and targets at ₹1,020.
PNBHOUSING drew 5 calls — 5 buy calls — from Manas Jaiswal, with entries between ₹1,165 and ₹1,182 and targets at ₹1,220.
AETHER attracted 4 buys from Stockpro Online (SEBI Reg. INH100006667) at ₹1,670 targeting ₹1,685, ₹1,700, ₹1,715 and ₹1,730 (stop ₹1,640).
The remaining 31 stocks covered by SEBI-registered analysts, with the price at which each call was issued:
Buy calls — PAYTM (₹1,811 → ₹1,600) via Bernstein, Jefferies; VARROC (₹880 → ₹920) via Elitewealthltd, Siddharth Ray Mangla; WABAG (₹2,195 → ₹2,300) via Kunal Saraogi; IDEA (₹15 → ₹20) via Jefferies; LAURUSLABS (₹1,972 → ₹2,010) via Manas Jaiswal; AEGISLOG (₹1,357 → ₹1,420) via Siddharth Ray Mangla; APLAPOLLO (₹2,141 → ₹2,220) via Prakash Gaba; IZMO (₹900 → ₹940) via Elitewealthltd.
MOBIKWIK (₹201 → ₹210) via Elitewealthltd; ONGC (₹238 → ₹244) via Elitewealthltd; POWERGRID27029SEP26CE (₹6 → ₹10) via Manas Jaiswal; POWERINDIA (₹356 → ₹385) via STOCKGAINERSS; TIMKEN (₹3,297 → ₹3,400) via Siddharth Ray Mangla; ACCURACY (₹3,443 → ₹3,650) via Lakshmishree; AMBALALSA (₹1,246 → ₹1,550) via CLSA; ARIES (₹483.95 → ₹20) via Jefferies.
BHARTIHEXA (₹1,555 → ₹1,612) via Nirmalbangofficial; BLUESTONE (₹884 → ₹950) via Lakshmishree; EMMVEE (₹336.5 → ₹365) via Lakshmishree; GRANULES (₹908 → ₹970) via Lakshmishree; HDFCLIFE (₹529 → ₹540) via Prakash Gaba; INDORAMA (₹86.2 → ₹100) via Lakshmishree; KEI (₹4,640 → ₹6,150) via Jefferies; LENSKART (₹689.6 → ₹800) via Siddharth Khemka.
MEESHO (₹222.5 → ₹236) via Icms1; NEOGEN (₹2,380.2 → ₹2,550) via OfficialHDFCsecurities; NEPHROPLUS (₹766 → ₹850) via Lakshmishree; ONEGLOBAL (₹15 → ₹20) via Jefferies; PNB (₹117.1 → ₹125) via Nirmalbangofficial; PWL (₹133.5 → ₹137.1) via Lakshmishree; TDPOWERSYS (₹794 → ₹850) via OfficialHDFCsecurities.
This roundup reproduces calls from 17 SEBI-registered Research Analysts: Bernstein (SEBI Reg. INH000006378); Jefferies (SEBI Reg. INH000000701); CLSA (SEBI Reg. INH000001113); Manas Jaiswal (SEBI Reg. INH100001625); Elitewealthltd (SEBI Reg. INH100002300); Lakshmishree (SEBI Reg. INH000014395); Siddharth Ray Mangla (SEBI Reg. INH000024693); Kunal Saraogi (SEBI Reg. INH100001609); Stockpro Online (SEBI Reg. INH100006667); Prakash Gaba (SEBI Reg. INH000001022); Nirmalbangofficial (SEBI Reg. INH000001436); OfficialHDFCsecurities (SEBI Reg. INH000002475); STOCKGAINERSS (SEBI Reg. INH100007879); a SEBI-registered analyst (SEBI Reg. INH000028592); Gaurang Shah (SEBI Reg. INH000019567); Icms1 (SEBI Reg. INH000002459); Siddharth Khemka (SEBI Reg. INH000000412).
Short-term calls are designed to play out over two to four weeks. Quarterly results, FII flows, and sector rotation remain key variables during the holding period.
All recommendations reproduced here originate exclusively from SEBI-registered Research Analysts and are published for informational purposes only. These are not buy or sell recommendations from this publication. Registration with SEBI does not guarantee returns. Investing in securities markets is subject to market risks — read all related documents carefully before investing.
Disclaimer
All recommendations published on Bharatstox are sourced exclusively from SEBI-registered Research Analysts. Registration with SEBI does not guarantee returns or the performance of the intermediary. Investing in securities markets is subject to market risks. Read all related documents carefully before investing. This article is for informational purposes only and does not constitute investment advice.